Accessibility Menu
Lifeloc Technologies logo

Lifeloc Technologies(OTC) LCTC

Market Cap$10.46MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2012)+4%
5 Year+12%
1 Year+23%
1 Month+28%
$3.80
+0.00%
+0.00Today
Lifeloc Technologies last closing stock price
MetricPriceDate
Last closeUSD 3.802026-07-30
Lifeloc Technologies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+10.93%USD 3.432026-07-23
1 month+27.95%USD 2.972026-06-30
3 month+94.87%USD 1.952026-05-01
Year to date+58.33%USD 2.402025-12-29
1 year+22.58%USD 3.102025-07-18
3 year+93.88%USD 1.962023-07-31
5 year+11.76%USD 3.402021-07-30
Since inception+3.83%USD 3.662012-03-22

Lifeloc Technologies Financials at a Glance

Market Cap

$10.46MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$9.04M

Net Income (TTM)

-$2.33M

EPS (TTM)

-$0.85

P/E Ratio

-4.49

Dividend

$0.00

Beta (Volatility)

0.11 (Low)

Price

$3.80

Volume

3,250

Open

$3.70

Previous Close

$3.80

Daily Range

$2.66 - $3.99

52-Week Range

$1.75 - $3.99

Estimated Earnings Date

Aug 7, 2024

LCTC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lifeloc Technologies

Lifeloc makes breathalyzers and drug testing tools for police, workplaces, and other markets.

Its devices help check if someone has alcohol or drugs in their system. These products support safety and compliance for employers and law enforcement.

Gadgets That Keep Tabs: Products and Services

  • Products segment (99.6% of revenue): Includes portable and fixed breath alcohol testing devices, accessories, supplies, and services, used by police and workplaces.
  • Drug Testing Products: Tools for screening drugs, including new rapid saliva-based systems in development.
  • Training and Services: Online and in-person courses for alcohol and drug testing program managers.
  • Accessories and Calibration: Supplies and equipment to keep testing devices accurate and ready.
  • Software Solutions: Management software for tracking and reporting alcohol test results.
  • Real Estate Rentals (0.4% of revenue in Q2 2025, discontinued June 2025): Rental income from commercial property, now ended.

Growth Spurts and New Tricks: Expansion Moves

  • Acquired training assets from Superior Training Solutions in 2014 to expand education offerings.
  • Launched Lifeloc University for online and mobile training in 2011.
  • Started beta testing the SpinDx drug testing platform with Anschutz Medical Center in 2025.
  • Expanded global sales through distributors and direct channels since 2012 IPO.
  • Ended commercial property rental business in June 2025 to use full headquarters space.

Why Lifeloc Stands Out in the Crowd

Lifeloc sells its products worldwide, reaching both domestic and international customers. The company focuses on innovation, like developing new drug testing technology that can detect active marijuana compounds.

Five Things You Need to Know

  • Revenue was $2,191,260 in Q2 2025, down 8% from Q2 2024.
  • Gross profit margin was relatively constant at 41% in Q2 2025 and Q2 2024.
  • Operating loss improved 4.7% to $-378,265 in Q2 2025.
  • International sales made up 37% of product sales in Q2 2025.

Bottom Line

Lifeloc has evolved from a single-product company to a diversified provider of testing devices and training. Its focus on innovation and adaptability helps it serve safety-focused markets worldwide.

AI Generated • Apr 16, 2026

Industry

Electronic Equipment, Instruments and Components

Sector

Information Technology

Employees

38

CEO

Wayne R. Willkomm, PhD

Website

www.lifeloc.com

Headquarters

Wheat Ridge, CO 80033, US

LCTC Financials

Key Financial Metrics (TTM)

Gross Margin

41.14%

Operating Margin

-11.91%

Net Income Margin

-25.77%

Return on Equity

-47.64%

Return on Capital

-20.74%

Return on Assets

-34.58%

Earnings Yield

-22.27%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$10.46MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.75M

Volume

3.25K

Avg. Volume

537.111

Financials (TTM)

Gross Profit

$3.72M

Operating Income

-$1.08M

EBITDA

-$686.18K

Operating Cash Flow

$52.14K

Capital Expenditure

-$153.39K

Free Cash Flow

-$101.26K

Cash & ST Invst.

$569.33K

Total Debt

$1.81M

Lifeloc Technologies Performance Analysis

Lifeloc Technologies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 8,481,99320.2%
20232023-12-31USD 9,329,56610.0%
20242024-12-31USD 8,538,145-8.5%
20252025-12-31USD 9,026,9385.7%
Lifeloc Technologies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-2.5%
Q32025-09-301.7%
Q42025-12-310.7%
Q12026-03-310.9%
Lifeloc Technologies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.19N/A
20232023-12-31USD 0.08N/A
20242024-12-31USD -0.41N/A
20252025-12-31USD -0.90118.2%
Lifeloc Technologies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-27.3%
Q32025-09-3028.6%
Q42025-12-31-450.0%
Q12026-03-3189.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$2.29M

+0.7%

Gross Profit

$987.07K

+8.6%

Gross Margin

43.03%

N/A

Market Cap

$10.46MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$275.26K

N/A

Employees

38

N/A

Net Income

-$152.71K

+47.8%

EBITDA

-$60.23K

+62.5%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$569.33K

-62.6%

Total Debt

$1.81M

-2.4%

Accounts Receivable

$906.32K

+7.6%

Inventory

$2.79M

-5.0%

Long Term Debt

$1.72M

-4.1%

Short Term Debt

$89.79K

+45.9%

Return on Assets

-34.58%

N/A

Return on Invested Capital

-18.99%

N/A

Free Cash Flow

-$149.15K

-7465.4%

Operating Cash Flow

-$129.37K

-6488.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ZTSTFZTEST Electronics Inc.
$0.29+32.18%
SEACSeaChange International, Inc.
$3.30+0.00%
PGNTParagon Technologies, Inc.
$4.69+0.00%
SCNDScientific Industries, Inc.
$0.60+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About LCTC

What is the current price of Lifeloc Technologies?

Lifeloc Technologies is trading at $3.80 per share.

What is the 52-week range for Lifeloc Technologies?

Over the past 52 weeks, Lifeloc Technologies has traded between $1.75 and $3.99.

How much debt does Lifeloc Technologies have?

As of the most recent reporting period, Lifeloc Technologies reported total debt of $1.81M.

How much cash does Lifeloc Technologies have on hand?

Lifeloc Technologies reported $569.33K in cash and cash equivalents in its most recent financial results.

What is Lifeloc Technologies’s dividend yield?

Lifeloc Technologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services